Recruiting

Efficacy and Safety of Auricular Acupuncture in Depression During the Covid 19 Pandemic

Participants with moderate depressive symptoms measured by PHQ-9 will be randomized to receive auricular acupuncture. The triple blinded procedure will be conducted in 12 sessions (6 weeks). The primary outcome is the response to the treatment 3 months after inclusion.

ClinicalTrials.gov IDNCT05855421
PhaseNA
Enrollment280
SponsorUniversidade do Sul de Santa Catarina
Age18 Years – 50 Years
SexALL
I'm interested View official listing

Conditions studied

Depressive Symptoms, Depression, Anxiety, Insomnia, Quality of Life

About this study

Participants with moderate depressive symptoms measured by PHQ-9 will be randomized to receive auricular acupuncture. The triple blinded procedure will be conducted in 12 sessions (6 weeks). The primary outcome is the response to the treatment 3 months after inclusion.

Interventions

Primary outcomes

Eligibility information

Inclusion Criteria: * Age between 18 and 50 years old * PHQ-9 score between 10 and 19 (moderate depression) * Availability for sessions Exclusion Criteria: Use complementary and integrative practices at the last 3 months; Suicidal risk evaluated by question number 9 in the PHQ-9 Severe depression score in the PHQ-9 Prior use of auricular acupuncture Pregnancy Menopause Tape and metal allergy

Study locations

Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.

Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-10-21.